{"name":"Poseida Therapeutics, Inc.","slug":"poseida-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":64703000,"revenueGrowth":-50.4,"grossMargin":0,"rdSpend":156772000,"netIncome":-123430000,"cash":44472000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2023"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9iVUFUYkF6aGt3akxZT0hGaW1LLTVITDlQdFFCYUZkc2IwaDJKSHZpQ1d2VmtPWldraV9yWm9idUZab0xqcWZzdXllQ1BIaF9WUGVxcFJMNWhPakFld2QzRVg2dElTbkZjVjdzcEY3QmtFRG96SzhTT25aMkY?oc=5","date":"2025-12-17","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOQk1TLXQwbDBUZmlGamkxYVRwNUZvb3BHYlgzZGpxNDVwd1REbzIxbmwzbmFRSlBfSmlicTlwblV1aXk2MGFPR1BXQ2s2ZUpEbEVkSVBVSHBqWXdzXzJpUmstLXlUTExVQU5yeTJTUkRrSlU1Nld0eksyY25mS0RPeXRrUjhZVkVubHRrMFpUU3hJb1dITE5IT3VwMTBaa1pEU2JvUWlaanc2d3RCd0FZ?oc=5","date":"2025-04-24","type":"pipeline","source":"Fierce Biotech","summary":"Tariffs will make financial case for pharma M&A 'more difficult,' says Roche CEO - Fierce Biotech","headline":"Tariffs will make financial case for pharma M&A 'more difficult,' says Roche CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNbW4xQ25zTmlfOWtOU1lydHlXVkZSQ01ILVVvclFwN0NkYkg0c28wQTVUQlkxdWhzcU1nSmNncGV5eVZkaUVSQ2RjUVZnSTdVVUFGTmpObkU1T3phRDFMbE9tX2lSb3NuRF9YbUJtWU5SNzZJQktMNFBiY2FtNE9mWVhQb3ZqU3NfM0E?oc=5","date":"2025-01-08","type":"deal","source":"BioProcess International","summary":"Major pharmaceutical company Roche buys cell and gene developer Poseida Therapeutics in $1.5 billion acquisition - BioProcess International","headline":"Major pharmaceutical company Roche buys cell and gene developer Poseida Therapeutics in $1.5 billion acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOczVIYkFydElrM1dyMGlhc2RTeFAtRlpUaWFwMDZ4MFFNWkN1NDlZa0J0RlUtTUJRSm1SM0VQQU4xZ2RPdkVlQ0dmak8xYkUzSGJFWEhYLXJxNmlUTjdRamh3dkl2NElzNUllWXd5dVotR0l1NWY5RjRNZlBFSUg2MFFWY2VLcFFwUU1PT0NhZkR6MlMy?oc=5","date":"2024-12-02","type":"deal","source":"Contract Pharma","summary":"Roche Agrees to Acquire Poseida Therapeutics - Contract Pharma","headline":"Roche Agrees to Acquire Poseida Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQcW52Rkd4ZE5zbVpubmJhN3N5NkpHSnVjUUNqSGxDNlZCZno0LVREOWtqNlRxVldQXzNzaWRMeEh0aTJYNloxV0l6aWE5MndneVR3RExyM0cwX1IwZjdWbXZEQW9SaG1zZVVEYXJSUWVRY05VSXlyU1djZ2c2VGVxLTNXNHJVN3kySXo0YkREV3VONThHcDF5VWFwYkxaUDB5UXd2UGlTVkE?oc=5","date":"2024-11-29","type":"deal","source":"San Diego Union-Tribune","summary":"Pharma giant Roche to buy San Diego biotech for up to $1.5B - San Diego Union-Tribune","headline":"Pharma giant Roche to buy San Diego biotech for up to $1.5B - San Diego Union","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNT21KX0VnbHlQTUp4Tk5WNGwzVjJmS0N0WXRHVGlkU19NaXRHWUJhTTZOb3RvNXVpdlBYZnYtZmhrWTJMNGxIZUhtRHNCUVVvZ2k4VzlfVGFBWnhNbzA5RVpWNXNQZEJhdkFVeHN0SHREWnllVWJac2pfRTViNVlPV1B3b2czU3BIQnJQZUFXckhTZTVFYXdLZVZMbG5ZaEFMUFBEaVBieGU0N3VjNEdpRng4VmRWc1QtSXI0Zjd5ODdlMVJNQ1lrM0tva0g4UDRIZFFv?oc=5","date":"2024-11-26","type":"deal","source":"PR Newswire","summary":"Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc. - PR Newswire","headline":"Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBwYTQwcVRydWNFME9fWm5IdnJVdHJNRzZYaVdPVkVIczR3LW9UUG1GNDVhd19udTJub29CNFJjXzc5WWFKblF4THRrQ1F0TTRONFFBMzBsNS1lWGl1Z0lOcElXNzBlTkIxbnRXRS1zWW9UZU1md3RweWprQXE?oc=5","date":"2024-11-26","type":"deal","source":"Pharmaceutical Technology","summary":"Roche to acquire Poseida Therapeutics for $1.5bn - Pharmaceutical Technology","headline":"Roche to acquire Poseida Therapeutics for $1.5bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNMXYySjR3Q3hWWjIxQ0lwcEc1dnZGeWpBci1UT2JSNkdoUEFYd05aY0d0bDF4VVVhWHhWTGVVYldIeHU0cldoM01MT1ptMHhfaWVIaThyRExOeXVYanl6S3hDbXlMSHpVRldicUI0RV8wam51UHA2c1h0MzhpMFVfOTRiVWFWdVp6V1lwS1ZxcE9udkpjSXRsNzcwTFpFLWNEZnc?oc=5","date":"2024-11-26","type":"pipeline","source":"BioSpace","summary":"Roche Nears Completion of Poseida Acquisition Worth Up to $1.5B - BioSpace","headline":"Roche Nears Completion of Poseida Acquisition Worth Up to $1.5B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPYkRaT1YtcGRPclpmWkoySFVFVWgxMzZDWm5rdjFlUF9MVmhYcTdpb0NvY0JCbTBWRE1yVEQyV1UxcmJUYU4zRjJXdmExQ3V3VFdzSEdpR014T3RvTjRyZjhjTkRvV0pUWUhOX0pZNTVNeEZRUjREVGFOV1BIaDM0alNzaEpIOEJHcGZaM2J0SlRIMnJtSDZ3bA?oc=5","date":"2024-11-26","type":"deal","source":"BioPharma Dive","summary":"Roche to buy cell therapy developer Poseida for $1B - BioPharma Dive","headline":"Roche to buy cell therapy developer Poseida for $1B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNVklScXhoQ24wNUI5TE1UMjZFM3FCSWphTkJLX2xBSDZINzFsRDB3MExJSTNiRG51bVY3NVljZ0hNdmtjaUJIWnRFVVZ2d1lXLVpkSWJyZEwtNE5QTmtsNTk0a202SmpNUVZlN1NtTmR0aFVEWWFKbGZUQ1FNSVFFVmRrNWNSWWpMSFRLY3hB?oc=5","date":"2024-11-26","type":"pipeline","source":"Barron's","summary":"Why Poseida Therapeutics Stock Is Rising 228% - Barron's","headline":"Why Poseida Therapeutics Stock Is Rising 228% - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPVWRsNHdHRm9tT1FqZl9PTHlKOEh4clduc01WMFFxRVJTQkVaRHVUTzU5cTNoZFlRS0dTX0xldlVlZ195RFdDQ3Rxd1QwbmFRWmVuT3duYTUtTmpTZmdyejhFRE9wTkJqLWpuWWVDNy1WSTN2YkpyT1JENjZmYk9feThpS2s1dlNGTE01cHk3TVJpUE9iZjlMRQ?oc=5","date":"2024-11-26","type":"pipeline","source":"MedCity News","summary":"Roche Expands Its Scope in Allogeneic Cell Therapy With $1B Poseida Therapeutics Acquisition - MedCity News","headline":"Roche Expands Its Scope in Allogeneic Cell Therapy With $1B Poseida Therapeutics Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxQMU14cHZqcWxjWm5SdWVlYzNibkppdTY2Y1NuMV9EOVdZM19oWUh0d3JqNXNENkFuQks2TG1IdEVIem1pYmREaU5LOVVBTVZUUEVQQkdmb3BNb1kzSkNGX2dxREthd21LRkcxX2h0WUJ6bkQtb0Z1OFJiUVhGb28xZVljS2taUnNiVG1TRE03MXkyTXR0MWF4RWthbmZmN2lkaFpSV3pJUlQtd3hDYXVRelZNbWxKSnJqOXcxckM3UE1BWkRIYUVxUmg3bndWeTA3WlJESUZWblptMGw3QzRxMlJoMVVEVTJfQVpZRlZJdXZLbUV1a2dZaGI2VWFaZE11YUJUaTBjdXJRb3BlS0lKX3Vn?oc=5","date":"2023-08-07","type":"pipeline","source":"PR Newswire","summary":"Astellas and Poseida Therapeutics Announce Strategic Investment to Support Poseida's Commitment to Redefining Cancer Cell Therapy - PR Newswire","headline":"Astellas and Poseida Therapeutics Announce Strategic Investment to Support Poseida's Commitment to Redefining Cancer Cel","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":64703000,"revenuePeriod":"2023-12-31","revenueHistory":[{"value":64703000,"period":"2023-12-31"},{"value":130492000,"period":"2022-12-31"},{"value":31238000,"period":"2021-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":156772000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-123430000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":44472000,"cashHistory":[],"totalAssets":273885000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}